ulbp2 5 6 Search Results


93
R&D Systems human ulbp2 5 6
Human Ulbp2 5 6, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human ulbp2 5 6/product/R&D Systems
Average 93 stars, based on 1 article reviews
human ulbp2 5 6 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

94
R&D Systems human ulbp 2 antibody
Human Ulbp 2 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human ulbp 2 antibody/product/R&D Systems
Average 94 stars, based on 1 article reviews
human ulbp 2 antibody - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

99
R&D Systems apc conjugated mouse anti hulbp2 5 6
Apc Conjugated Mouse Anti Hulbp2 5 6, supplied by R&D Systems, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/apc conjugated mouse anti hulbp2 5 6/product/R&D Systems
Average 99 stars, based on 1 article reviews
apc conjugated mouse anti hulbp2 5 6 - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

99
R&D Systems ulbp1
Ulbp1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ulbp1/product/R&D Systems
Average 99 stars, based on 1 article reviews
ulbp1 - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

92
R&D Systems anti human ulbp2 5 6 antibody
Anti Human Ulbp2 5 6 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti human ulbp2 5 6 antibody/product/R&D Systems
Average 92 stars, based on 1 article reviews
anti human ulbp2 5 6 antibody - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier

93
R&D Systems mouse monoclonal igg antibodies
Mouse Monoclonal Igg Antibodies, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal igg antibodies/product/R&D Systems
Average 93 stars, based on 1 article reviews
mouse monoclonal igg antibodies - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

94
R&D Systems ulbp2
IP induces dose‐dependent cell surface NKG2D ligand expression. (A) NKG2D ligands are not typically expressed on healthy quiescent cells. Stimuli including malignant transformation, viral infection, and proliferative lymphocyte activation are associated with NKG2D ligand induction. Expression can cause cytotoxicity, cytokine secretion, or costimulation through binding to the activating receptor, NKG2D. (B) HEK293T cells were cultured in 5 mM glucose with 0.25, 1, or 2 mM IP for 48 h, and cell surface expression of MICA (2C10) was measured by flow cytometry. A strong dose‐dependent increase in MICA expression was observed. Isotype controls (dotted histogram), cells cultured in 5 mM glucose only (light grey shaded histogram) or in 25 mM glucose (dark grey shaded histogram) are also shown. (C) Cells were cultured in 5 or 25 mM glucose with IP in biological triplicates and MICA expression was measured by flow cytometry. In 5 mM glucose, IP produced a significant increase in cell surface MICA expression compared to untreated cells. In 25 mM glucose, a significant increase in MICA expression was observed at higher IP concentrations. (D) HEK293T cells, (E) HT1080 cells (human fibrosarcoma), and (F) HeLa cells (human cervical carcinoma) demonstrate dose‐dependent MICA (2C10) expression when cultured with IP. (G) We tested whether IP influenced total cellular MICA levels by staining permeabilized and non‐permeabilized cells in parallel. Permeabilized cells displayed the same dose‐dependent IP‐induced MICA expression as non‐permeabilized cells. (H) We tested for adequate cell permeabilization by measuring the expression of PCNA (14‐9910‐80) in both non‐permeabilized and permeabilized cells by flow cytometry. PCNA was only detected in permeabilized cells and did not increase in an IP‐dependent manner. (I) The effect of IP on the induction of multiple NKG2D ligands including MICB (MAB1599), ULBP1 (MAB1380), <t>ULBP2</t> <t>(MAB1298),</t> ULBP3 (MAB1517), ULBP4 (6E6), and ULBP5 (6D10) was tested by flow cytometry. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; and ∗∗∗∗ p < 0.0001. Histograms represent mean and 95% confidence interval. The data shown is from a single experiment that contained three biological replicates. Experiments were performed independently three times with consistent results. Means were compared using t ‐tests. MFI, mean fluorescence intensity.
Ulbp2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ulbp2/product/R&D Systems
Average 94 stars, based on 1 article reviews
ulbp2 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

93
R&D Systems human ulbp
IP induces dose‐dependent cell surface NKG2D ligand expression. (A) NKG2D ligands are not typically expressed on healthy quiescent cells. Stimuli including malignant transformation, viral infection, and proliferative lymphocyte activation are associated with NKG2D ligand induction. Expression can cause cytotoxicity, cytokine secretion, or costimulation through binding to the activating receptor, NKG2D. (B) HEK293T cells were cultured in 5 mM glucose with 0.25, 1, or 2 mM IP for 48 h, and cell surface expression of MICA (2C10) was measured by flow cytometry. A strong dose‐dependent increase in MICA expression was observed. Isotype controls (dotted histogram), cells cultured in 5 mM glucose only (light grey shaded histogram) or in 25 mM glucose (dark grey shaded histogram) are also shown. (C) Cells were cultured in 5 or 25 mM glucose with IP in biological triplicates and MICA expression was measured by flow cytometry. In 5 mM glucose, IP produced a significant increase in cell surface MICA expression compared to untreated cells. In 25 mM glucose, a significant increase in MICA expression was observed at higher IP concentrations. (D) HEK293T cells, (E) HT1080 cells (human fibrosarcoma), and (F) HeLa cells (human cervical carcinoma) demonstrate dose‐dependent MICA (2C10) expression when cultured with IP. (G) We tested whether IP influenced total cellular MICA levels by staining permeabilized and non‐permeabilized cells in parallel. Permeabilized cells displayed the same dose‐dependent IP‐induced MICA expression as non‐permeabilized cells. (H) We tested for adequate cell permeabilization by measuring the expression of PCNA (14‐9910‐80) in both non‐permeabilized and permeabilized cells by flow cytometry. PCNA was only detected in permeabilized cells and did not increase in an IP‐dependent manner. (I) The effect of IP on the induction of multiple NKG2D ligands including MICB (MAB1599), ULBP1 (MAB1380), <t>ULBP2</t> <t>(MAB1298),</t> ULBP3 (MAB1517), ULBP4 (6E6), and ULBP5 (6D10) was tested by flow cytometry. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; and ∗∗∗∗ p < 0.0001. Histograms represent mean and 95% confidence interval. The data shown is from a single experiment that contained three biological replicates. Experiments were performed independently three times with consistent results. Means were compared using t ‐tests. MFI, mean fluorescence intensity.
Human Ulbp, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human ulbp/product/R&D Systems
Average 93 stars, based on 1 article reviews
human ulbp - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
R&D Systems biotinylated goat polyclonal anti ulbp2 5 6 baf1298
IP induces dose‐dependent cell surface NKG2D ligand expression. (A) NKG2D ligands are not typically expressed on healthy quiescent cells. Stimuli including malignant transformation, viral infection, and proliferative lymphocyte activation are associated with NKG2D ligand induction. Expression can cause cytotoxicity, cytokine secretion, or costimulation through binding to the activating receptor, NKG2D. (B) HEK293T cells were cultured in 5 mM glucose with 0.25, 1, or 2 mM IP for 48 h, and cell surface expression of MICA (2C10) was measured by flow cytometry. A strong dose‐dependent increase in MICA expression was observed. Isotype controls (dotted histogram), cells cultured in 5 mM glucose only (light grey shaded histogram) or in 25 mM glucose (dark grey shaded histogram) are also shown. (C) Cells were cultured in 5 or 25 mM glucose with IP in biological triplicates and MICA expression was measured by flow cytometry. In 5 mM glucose, IP produced a significant increase in cell surface MICA expression compared to untreated cells. In 25 mM glucose, a significant increase in MICA expression was observed at higher IP concentrations. (D) HEK293T cells, (E) HT1080 cells (human fibrosarcoma), and (F) HeLa cells (human cervical carcinoma) demonstrate dose‐dependent MICA (2C10) expression when cultured with IP. (G) We tested whether IP influenced total cellular MICA levels by staining permeabilized and non‐permeabilized cells in parallel. Permeabilized cells displayed the same dose‐dependent IP‐induced MICA expression as non‐permeabilized cells. (H) We tested for adequate cell permeabilization by measuring the expression of PCNA (14‐9910‐80) in both non‐permeabilized and permeabilized cells by flow cytometry. PCNA was only detected in permeabilized cells and did not increase in an IP‐dependent manner. (I) The effect of IP on the induction of multiple NKG2D ligands including MICB (MAB1599), ULBP1 (MAB1380), <t>ULBP2</t> <t>(MAB1298),</t> ULBP3 (MAB1517), ULBP4 (6E6), and ULBP5 (6D10) was tested by flow cytometry. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; and ∗∗∗∗ p < 0.0001. Histograms represent mean and 95% confidence interval. The data shown is from a single experiment that contained three biological replicates. Experiments were performed independently three times with consistent results. Means were compared using t ‐tests. MFI, mean fluorescence intensity.
Biotinylated Goat Polyclonal Anti Ulbp2 5 6 Baf1298, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/biotinylated goat polyclonal anti ulbp2 5 6 baf1298/product/R&D Systems
Average 93 stars, based on 1 article reviews
biotinylated goat polyclonal anti ulbp2 5 6 baf1298 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
R&D Systems anti human ulbp1
IP induces dose‐dependent cell surface NKG2D ligand expression. (A) NKG2D ligands are not typically expressed on healthy quiescent cells. Stimuli including malignant transformation, viral infection, and proliferative lymphocyte activation are associated with NKG2D ligand induction. Expression can cause cytotoxicity, cytokine secretion, or costimulation through binding to the activating receptor, NKG2D. (B) HEK293T cells were cultured in 5 mM glucose with 0.25, 1, or 2 mM IP for 48 h, and cell surface expression of MICA (2C10) was measured by flow cytometry. A strong dose‐dependent increase in MICA expression was observed. Isotype controls (dotted histogram), cells cultured in 5 mM glucose only (light grey shaded histogram) or in 25 mM glucose (dark grey shaded histogram) are also shown. (C) Cells were cultured in 5 or 25 mM glucose with IP in biological triplicates and MICA expression was measured by flow cytometry. In 5 mM glucose, IP produced a significant increase in cell surface MICA expression compared to untreated cells. In 25 mM glucose, a significant increase in MICA expression was observed at higher IP concentrations. (D) HEK293T cells, (E) HT1080 cells (human fibrosarcoma), and (F) HeLa cells (human cervical carcinoma) demonstrate dose‐dependent MICA (2C10) expression when cultured with IP. (G) We tested whether IP influenced total cellular MICA levels by staining permeabilized and non‐permeabilized cells in parallel. Permeabilized cells displayed the same dose‐dependent IP‐induced MICA expression as non‐permeabilized cells. (H) We tested for adequate cell permeabilization by measuring the expression of PCNA (14‐9910‐80) in both non‐permeabilized and permeabilized cells by flow cytometry. PCNA was only detected in permeabilized cells and did not increase in an IP‐dependent manner. (I) The effect of IP on the induction of multiple NKG2D ligands including MICB (MAB1599), ULBP1 (MAB1380), <t>ULBP2</t> <t>(MAB1298),</t> ULBP3 (MAB1517), ULBP4 (6E6), and ULBP5 (6D10) was tested by flow cytometry. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; and ∗∗∗∗ p < 0.0001. Histograms represent mean and 95% confidence interval. The data shown is from a single experiment that contained three biological replicates. Experiments were performed independently three times with consistent results. Means were compared using t ‐tests. MFI, mean fluorescence intensity.
Anti Human Ulbp1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti human ulbp1/product/R&D Systems
Average 93 stars, based on 1 article reviews
anti human ulbp1 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

91
R&D Systems anti ulbp2
IP induces dose‐dependent cell surface NKG2D ligand expression. (A) NKG2D ligands are not typically expressed on healthy quiescent cells. Stimuli including malignant transformation, viral infection, and proliferative lymphocyte activation are associated with NKG2D ligand induction. Expression can cause cytotoxicity, cytokine secretion, or costimulation through binding to the activating receptor, NKG2D. (B) HEK293T cells were cultured in 5 mM glucose with 0.25, 1, or 2 mM IP for 48 h, and cell surface expression of MICA (2C10) was measured by flow cytometry. A strong dose‐dependent increase in MICA expression was observed. Isotype controls (dotted histogram), cells cultured in 5 mM glucose only (light grey shaded histogram) or in 25 mM glucose (dark grey shaded histogram) are also shown. (C) Cells were cultured in 5 or 25 mM glucose with IP in biological triplicates and MICA expression was measured by flow cytometry. In 5 mM glucose, IP produced a significant increase in cell surface MICA expression compared to untreated cells. In 25 mM glucose, a significant increase in MICA expression was observed at higher IP concentrations. (D) HEK293T cells, (E) HT1080 cells (human fibrosarcoma), and (F) HeLa cells (human cervical carcinoma) demonstrate dose‐dependent MICA (2C10) expression when cultured with IP. (G) We tested whether IP influenced total cellular MICA levels by staining permeabilized and non‐permeabilized cells in parallel. Permeabilized cells displayed the same dose‐dependent IP‐induced MICA expression as non‐permeabilized cells. (H) We tested for adequate cell permeabilization by measuring the expression of PCNA (14‐9910‐80) in both non‐permeabilized and permeabilized cells by flow cytometry. PCNA was only detected in permeabilized cells and did not increase in an IP‐dependent manner. (I) The effect of IP on the induction of multiple NKG2D ligands including MICB (MAB1599), ULBP1 (MAB1380), <t>ULBP2</t> <t>(MAB1298),</t> ULBP3 (MAB1517), ULBP4 (6E6), and ULBP5 (6D10) was tested by flow cytometry. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; and ∗∗∗∗ p < 0.0001. Histograms represent mean and 95% confidence interval. The data shown is from a single experiment that contained three biological replicates. Experiments were performed independently three times with consistent results. Means were compared using t ‐tests. MFI, mean fluorescence intensity.
Anti Ulbp2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti ulbp2/product/R&D Systems
Average 91 stars, based on 1 article reviews
anti ulbp2 - by Bioz Stars, 2026-03
91/100 stars
  Buy from Supplier

91
R&D Systems antiulbp2
IP induces dose‐dependent cell surface NKG2D ligand expression. (A) NKG2D ligands are not typically expressed on healthy quiescent cells. Stimuli including malignant transformation, viral infection, and proliferative lymphocyte activation are associated with NKG2D ligand induction. Expression can cause cytotoxicity, cytokine secretion, or costimulation through binding to the activating receptor, NKG2D. (B) HEK293T cells were cultured in 5 mM glucose with 0.25, 1, or 2 mM IP for 48 h, and cell surface expression of MICA (2C10) was measured by flow cytometry. A strong dose‐dependent increase in MICA expression was observed. Isotype controls (dotted histogram), cells cultured in 5 mM glucose only (light grey shaded histogram) or in 25 mM glucose (dark grey shaded histogram) are also shown. (C) Cells were cultured in 5 or 25 mM glucose with IP in biological triplicates and MICA expression was measured by flow cytometry. In 5 mM glucose, IP produced a significant increase in cell surface MICA expression compared to untreated cells. In 25 mM glucose, a significant increase in MICA expression was observed at higher IP concentrations. (D) HEK293T cells, (E) HT1080 cells (human fibrosarcoma), and (F) HeLa cells (human cervical carcinoma) demonstrate dose‐dependent MICA (2C10) expression when cultured with IP. (G) We tested whether IP influenced total cellular MICA levels by staining permeabilized and non‐permeabilized cells in parallel. Permeabilized cells displayed the same dose‐dependent IP‐induced MICA expression as non‐permeabilized cells. (H) We tested for adequate cell permeabilization by measuring the expression of PCNA (14‐9910‐80) in both non‐permeabilized and permeabilized cells by flow cytometry. PCNA was only detected in permeabilized cells and did not increase in an IP‐dependent manner. (I) The effect of IP on the induction of multiple NKG2D ligands including MICB (MAB1599), ULBP1 (MAB1380), <t>ULBP2</t> <t>(MAB1298),</t> ULBP3 (MAB1517), ULBP4 (6E6), and ULBP5 (6D10) was tested by flow cytometry. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; and ∗∗∗∗ p < 0.0001. Histograms represent mean and 95% confidence interval. The data shown is from a single experiment that contained three biological replicates. Experiments were performed independently three times with consistent results. Means were compared using t ‐tests. MFI, mean fluorescence intensity.
Antiulbp2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antiulbp2/product/R&D Systems
Average 91 stars, based on 1 article reviews
antiulbp2 - by Bioz Stars, 2026-03
91/100 stars
  Buy from Supplier

Image Search Results


IP induces dose‐dependent cell surface NKG2D ligand expression. (A) NKG2D ligands are not typically expressed on healthy quiescent cells. Stimuli including malignant transformation, viral infection, and proliferative lymphocyte activation are associated with NKG2D ligand induction. Expression can cause cytotoxicity, cytokine secretion, or costimulation through binding to the activating receptor, NKG2D. (B) HEK293T cells were cultured in 5 mM glucose with 0.25, 1, or 2 mM IP for 48 h, and cell surface expression of MICA (2C10) was measured by flow cytometry. A strong dose‐dependent increase in MICA expression was observed. Isotype controls (dotted histogram), cells cultured in 5 mM glucose only (light grey shaded histogram) or in 25 mM glucose (dark grey shaded histogram) are also shown. (C) Cells were cultured in 5 or 25 mM glucose with IP in biological triplicates and MICA expression was measured by flow cytometry. In 5 mM glucose, IP produced a significant increase in cell surface MICA expression compared to untreated cells. In 25 mM glucose, a significant increase in MICA expression was observed at higher IP concentrations. (D) HEK293T cells, (E) HT1080 cells (human fibrosarcoma), and (F) HeLa cells (human cervical carcinoma) demonstrate dose‐dependent MICA (2C10) expression when cultured with IP. (G) We tested whether IP influenced total cellular MICA levels by staining permeabilized and non‐permeabilized cells in parallel. Permeabilized cells displayed the same dose‐dependent IP‐induced MICA expression as non‐permeabilized cells. (H) We tested for adequate cell permeabilization by measuring the expression of PCNA (14‐9910‐80) in both non‐permeabilized and permeabilized cells by flow cytometry. PCNA was only detected in permeabilized cells and did not increase in an IP‐dependent manner. (I) The effect of IP on the induction of multiple NKG2D ligands including MICB (MAB1599), ULBP1 (MAB1380), ULBP2 (MAB1298), ULBP3 (MAB1517), ULBP4 (6E6), and ULBP5 (6D10) was tested by flow cytometry. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; and ∗∗∗∗ p < 0.0001. Histograms represent mean and 95% confidence interval. The data shown is from a single experiment that contained three biological replicates. Experiments were performed independently three times with consistent results. Means were compared using t ‐tests. MFI, mean fluorescence intensity.

Journal: European Journal of Immunology

Article Title: Inosine pranobex enhances human NK cell cytotoxicity by inducing metabolic activation and NKG2D ligand expression

doi: 10.1002/eji.201847948

Figure Lengend Snippet: IP induces dose‐dependent cell surface NKG2D ligand expression. (A) NKG2D ligands are not typically expressed on healthy quiescent cells. Stimuli including malignant transformation, viral infection, and proliferative lymphocyte activation are associated with NKG2D ligand induction. Expression can cause cytotoxicity, cytokine secretion, or costimulation through binding to the activating receptor, NKG2D. (B) HEK293T cells were cultured in 5 mM glucose with 0.25, 1, or 2 mM IP for 48 h, and cell surface expression of MICA (2C10) was measured by flow cytometry. A strong dose‐dependent increase in MICA expression was observed. Isotype controls (dotted histogram), cells cultured in 5 mM glucose only (light grey shaded histogram) or in 25 mM glucose (dark grey shaded histogram) are also shown. (C) Cells were cultured in 5 or 25 mM glucose with IP in biological triplicates and MICA expression was measured by flow cytometry. In 5 mM glucose, IP produced a significant increase in cell surface MICA expression compared to untreated cells. In 25 mM glucose, a significant increase in MICA expression was observed at higher IP concentrations. (D) HEK293T cells, (E) HT1080 cells (human fibrosarcoma), and (F) HeLa cells (human cervical carcinoma) demonstrate dose‐dependent MICA (2C10) expression when cultured with IP. (G) We tested whether IP influenced total cellular MICA levels by staining permeabilized and non‐permeabilized cells in parallel. Permeabilized cells displayed the same dose‐dependent IP‐induced MICA expression as non‐permeabilized cells. (H) We tested for adequate cell permeabilization by measuring the expression of PCNA (14‐9910‐80) in both non‐permeabilized and permeabilized cells by flow cytometry. PCNA was only detected in permeabilized cells and did not increase in an IP‐dependent manner. (I) The effect of IP on the induction of multiple NKG2D ligands including MICB (MAB1599), ULBP1 (MAB1380), ULBP2 (MAB1298), ULBP3 (MAB1517), ULBP4 (6E6), and ULBP5 (6D10) was tested by flow cytometry. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; and ∗∗∗∗ p < 0.0001. Histograms represent mean and 95% confidence interval. The data shown is from a single experiment that contained three biological replicates. Experiments were performed independently three times with consistent results. Means were compared using t ‐tests. MFI, mean fluorescence intensity.

Article Snippet: MICA (2C10, IgG1), ULBP4 (6E6, IgG2B), and ULBP5 (6D10, IgM) were purchased from Santa Cruz (Santa Cruz, CA); MICB (MAB1599, IgG2b), ULBP1 (MAB1380, IgG2a), ULBP2 (MAB1298, IgG2a), and ULBP3 (MAB1517, IgG2a) were purchased from R&D Systems (Minneapolis, MN).

Techniques: Expressing, Transformation Assay, Infection, Activation Assay, Binding Assay, Cell Culture, Flow Cytometry, Produced, Staining, Fluorescence